Pulmonary aspergillosis and mucormycosis in a patient with COVID-19

Link to article at PubMed

Med Mycol Case Rep. 2021 Apr 7. doi: 10.1016/j.mmcr.2021.03.006. Online ahead of print.


Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.

PMID:33842203 | PMC:PMC8025540 | DOI:10.1016/j.mmcr.2021.03.006

Leave a Reply

Your email address will not be published.